• TOPMed10
    Marie Sklodowska-Curie Actions COFUND Programme

Meet our PIs

Meet our PIs

Listed below are the Principal Investigators for our current call. Have a look through their research programme description and key words, and explore the links to their more detailed UCD profiles.

Once you have identified a potential supervisor, get in touch with them! This is a critical step as it gives you the chance to find out more about their lab and to see if you would be happy working with them. Once you have decided on your supervisor, you will work with them to formulate the project proposal that you will submit to the programme.


Dolores Cahill

Professor of Translational Science

Dolores’ area of research is in proteomics, protein arrays and biomarker validation. She has successfully commercialised her research in Protagen AG involved in commercialisation of companion diagnostics and Protagen Contract Services. She is now exploring application in personalised medicine and diagnostic contract services.

email | web


Glen Doherty

Senior Clinical Lecturer & Consultant Physician and Gastroenterologist, Centre for Colorectal Disease, St Vincent’s University Hospital

anti-TNF  |  inflammatory bowel disease  |  faecal calprotectin  |  therapeutic drug monitoring  |  monoclonal antibody

Glen’s interests include translational research to personalise therapy for inflammatory bowel diseases (Crohn’s Disease and Ulcerative Colitis) by optimising anti-TNF dosing and discovery of biomarkers/mechanisms of primary and secondary non- response.

email | web


William Gallagher

Professor of Cancer Biology, Director BREAST-PREDICT

cancer biology  |  transcriptomics  |  molecular diagnostics  |  therapeutics  |  breast

William’s team looks to deliver optimal management of cancer diagnosis and treatment via efficient use of protein and/or RNA-based biomarkers, digital pathology and systems medicine tools.

email | web


Breandán Kennedy

Senior Lecturer, UCD Conway Fellow

blindness  |  drug discovery  |  proteomics  |  neuroprotectants

Breandán’s research utilises phenotype-based assays to discover and develop novel drugs and new therapeutic targets for blindness and cancer. In parallel, CRISPR technology functionally interrogates gene networks and generates disease models. 

email | web


Patricia Maguire

Senior Lecturer, UCD Conway Fellow (pictured)

Fionnuala Ní Áinle

Consultant Haematologist, Mater Misericordiae University Hospital , UCD School of Medicine and Rotunda Maternity Hospital

Patricia and Fionnuala co-direct SPHERE, a UCD Conway Institute-based research group. They aim to harness unique haematological tools to diagnose and understand a host of inflammatory-based diseases.  

email | web


Helen Roche

Associate Professor of Nutrigenomics

nutrigenomics  |  precision nutrition  |  molecular nutrition  |  personalised nutrition & health

Helen’s team uses high throughput data approaches to further understand the interactions between nutritional status and metabolic health; we are actively looking to develop advanced systems biology models and approaches to support this work.

email | web


Colm Ryan

Sir Henry Wellcome Fellow, Systems Biology Ireland

cancer  |  genetics  |  proteomics  |  bioinformatics  |  systems biology

Colm's research uses network biology approaches to identify vulnerabilities associated with specific genetic aberrations in cancer. 

email | web


Martin Steinhoff

Professorial Chair of Dermatology and Director UCD Charles Institute of Dermatology

skin research  |  inflammation  |  oncology  |  omics technology  |  immunity

Martin’s translational research addresses how the immune and nervous system communicate and influence skin diseases using -omics, imaging, molecular biology, immunology, in-vivo models, human studies.

email | web


G‌erry Wilson

Professor of Rheumatology, UCD School of Medicine & Medical Science

inflammation  |  tissue damage  |  genetics  |  epigenetics  |  patient stratification

Gerry’s research area is identification of prognostic and therapeutic response biomarkers in rheumatoid arthritis and functional studies on pathways regulating inflammation-related tissue damage.

email | web